ICG PULSION PDF
To view details for ICG-PULSION, please read and accept the disclaimer or go back to product listing for INDOCYANINE GREEN. I have read and understand. The administration and site of ICG-PULSION are of critical importance for the quality of the measurements, In principle, for obtaining optimal. Icg-Pulsion drug information: uses, indications, side effects, dosage, pregnancy, precautions. Compare prices for generic icg-pulsion substitutes.
|Published (Last):||21 March 2013|
|PDF File Size:||16.49 Mb|
|ePub File Size:||12.76 Mb|
|Price:||Free* [*Free Regsitration Required]|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances. The easiest way to lookup drug information, identify pills, check interactions and set up your own personal medication records. Available for Android and iOS devices. Subscribe to receive email notifications whenever new articles are published.
This material is pulsino for educational purposes only and is not intended for medical advice, diagnosis or treatment. To view content sources and attributions, please refer to our editorial policy. We comply with the HONcode standard for trustworthy health information – verify here.
You may need to read it again. If you have any questions, ask your doctor or pharmacist or nurse. This medicine has been prescribed for you only. Do not pass it on to others.
It may harm them, even if their signs of illness are the same as yours. If you get any side effects, talk to your doctor or pharmacist or nurse.
This includes any possible side effects not listed in this leaflet. What is in this leaflet: The active substance in the solution is called indocyanine green, a coloured dye. This dye is then injected into one of your veins, where it mixes with your blood. The doctor will then be able to see: What it is used for It is used for diagnosis only, to find out which medical problems you may have, for example: Special patient groups Premature babies and pupsion infants If suffering from hyperbilirubinaemia, an illness in which there is an unusually large amount of bilirubin in their bloodpremature babies and new-born infants should not receive ICG-PULSION.
Consult your doctor to see whether this medicine is suitable for you. Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription.
PULSION Medical Systems SE: PULSION receives US approval for ICG-PULSION
Your doctor will decide if it is appropriate to give you this medicine. Ask your doctor or pharmacist for advice before taking any medicine. Driving and using machines No studies of the effects on the ability to drive and use machines have been performed.
Please check with your doctor before you consider driving or using machinery immediately after an injection. If it is cloudy, it will not be used.
This is to make it easier to put the needle into the vein. This is to prevent the samples from clotting. For assessing liver function, the recommended dose is 0.
Maximum daily dose Adults and the elderly: After the injection your doctor may measure how much dye there is in relation to the amount of blood.
Measurements are usually taken at an artery, a finger or an earlobe. You can ask your doctor to explain the techniques associated with your procedure.
If you use more of this medicine than you should Please tell your doctor if you think you have been given too much of the medicine. If you have any further questions on the use of this medicinal product, ask your doctor or pharmacist. Very rare affects fewer than one in every 10, patients: Together with the symptoms of the allergic reaction an increase of special white blood cells associated with allergic reactions can occur hypereosinophilia.
The possibility of an allergic reaction is greater in patients with extremely serious kidney failure. In the case of a severe allergic reaction, it may be necessary for you to receive emergency treatment such as: Reporting of side effects If you get any side effects, talk to your doctor or pharmacist or nurse.
You can also report side effects directly via the national reporting system Yellow Card Scheme, Website: Keep the glass vials in the outer carton in order to protect from light.
Once the solution for injection is prepared, it must be protected from light and used immediately. Only use clear solutions free from visible particles. The expiry date refers to the last day of that month. Do not throw away any medicines via waste water or household waste.
Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment. Each amber glass vial contains: The container is sealed with a grey rubber stopper and fixed with an aluminium cap covered by a blue polypropylene cap.
The following information is only intended for medical or healthcare professionals only: Handling instructions This medicinal product should be reconstituted immediately prior to use. If an incompatibility is noted in the form of unclear solution then the reconstituted solution should be discarded. Visually inspect the reconstituted solution. This medicinal product is for single use only.
Puulsion Drug Information Updates. Ultomiris Ultomiris ravulizumab-cwvz is a long-acting C5 complement inhibitor for the treatment of paroxysmal Xospata Xospata gilteritinib is a kinase inhibitor indicated for the treatment of patients who have relapsed or Daurismo Daurismo glasdegib is a hedgehog pathway inhibitor indicated for the combination treatment of adult Vitrakvi Vitrakvi larotrectinib is an oral selective tropomyosin receptor kinase TRK inhibitor for the treatment